Literature DB >> 21440575

A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.

Charlotte Bonardi1, Felicity de Pulford, Dómhnall Jennings, Marie-Christine Pardon.   

Abstract

Alzheimer's disease (AD) is an incurable age-related neurodegenerative condition, characterised by progressive decline in cognitive and physical functions, and extensive brain damage. Identifying cognitive deficits that accompany early AD is critical, as the accompanying synaptic changes can be effectively targeted by current treatments - at present AD is typically not diagnosed until brain pathology is established, and treatment relatively ineffective. We therefore examined early cognitive changes in 4-month-old mice over-expressing 2 genes responsible for AD (APPswe/PS1d9 mouse line). Experiment 1 tested 4-month-old female APPswe/PS1dE9 mice and their wild-type littermates on 4 validated tasks involving 8 cognitive and non cognitive measures. We observed a selective deficit in extinction of contextual fear in APPswe/PS1dE9 mice. To extend the generality of this finding, Experiment 2 examined conditioning and extinction of an auditory stimulus paired with a sucrose reinforcer. No effect of genotype was observed. A third experiment investigated whether the context extinction impairment could be attributed to an attentional deficit. One conditioning stimulus (CS) was preexposed without consequence, and then it and a second, novel auditory CS were paired with food. Preexposure produced equal retardation of conditioning of the preexposed CS in both genotypes. However, in Experiment 2, and marginally in Experiment 3, additional tests revealed evidence of a selective impairment in context extinction in transgenic mice. These data suggest that context extinction deficits precede other cognitive impairments in APPswe/PS1dE9 mice, an effect that has intriguing parallels with findings in patients with mild AD.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21440575     DOI: 10.1016/j.bbr.2011.03.041

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  14 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

2.  Impairments in Fear Extinction Memory and Basolateral Amygdala Plasticity in the TgF344-AD Rat Model of Alzheimer's Disease Are Distinct from Nonpathological Aging.

Authors:  Caesar M Hernandez; Nateka L Jackson; Abbi R Hernandez; Lori L McMahon
Journal:  eNeuro       Date:  2022-06-27

Review 3.  CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

Authors:  Nancy Bartolotti; Orly Lazarov
Journal:  Brain Behav Immun       Date:  2019-01-12       Impact factor: 7.217

Review 4.  Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

Authors:  Daniela Puzzo; Linda Lee; Agostino Palmeri; Giorgio Calabrese; Ottavio Arancio
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

5.  Impaired burrowing is the most prominent behavioral deficit of aging htau mice.

Authors:  Philippine Camilla Geiszler; Matthew Richard Barron; Marie-Christine Pardon
Journal:  Neuroscience       Date:  2016-05-07       Impact factor: 3.590

6.  Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer's disease.

Authors:  Marlene J Végh; Céline M Heldring; Willem Kamphuis; Sara Hijazi; Arie J Timmerman; Ka Wan Li; Pim van Nierop; Huibert D Mansvelder; Elly M Hol; August B Smit; Ronald E van Kesteren
Journal:  Acta Neuropathol Commun       Date:  2014-06-29       Impact factor: 7.801

7.  Abnormal Population Responses in the Somatosensory Cortex of Alzheimer's Disease Model Mice.

Authors:  Yossi Maatuf; Edward A Stern; Hamutal Slovin
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

8.  Magnetic Resonance Spectroscopy discriminates the response to microglial stimulation of wild type and Alzheimer's disease models.

Authors:  Marie-Christine Pardon; Maria Yanez Lopez; Ding Yuchun; Małgorzata Marjańska; Malcolm Prior; Christopher Brignell; Samira Parhizkar; Alessandra Agostini; Li Bai; Dorothee P Auer; Henryk M Faas
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

9.  Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease.

Authors:  Reddy Peera Kommaddi; Debajyoti Das; Smitha Karunakaran; Siddharth Nanguneri; Deepti Bapat; Ajit Ray; Eisha Shaw; David A Bennett; Deepak Nair; Vijayalakshmi Ravindranath
Journal:  J Neurosci       Date:  2017-12-15       Impact factor: 6.167

10.  The Aβ Containing Brain Extracts Having Different Effects in Alzheimer's Disease Transgenic Caenorhabditis elegans and Mice.

Authors:  Yufang Yang; Mo Wang; Ping Yang; Zishan Wang; Li Huang; Jing Xu; Wei Wang; Mei Yu; Liping Bu; Jian Fei; Fang Huang
Journal:  Front Aging Neurosci       Date:  2018-07-31       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.